Andersen, Amalie K. https://orcid.org/0009-0005-3983-8681
Lyng, Kristian D. https://orcid.org/0000-0001-8668-691X
Færch, Kristine https://orcid.org/0000-0002-6127-0448
Vistisen, Dorte https://orcid.org/0000-0001-5045-5351
von Scholten, Bernt J. https://orcid.org/0000-0002-1489-0636
Rathleff, Michael S. https://orcid.org/0000-0003-1173-0335
Thomsen, Janus L. https://orcid.org/0000-0002-0745-6815
Jensen, Morten H. https://orcid.org/0000-0002-6649-8644
Funding for this research was provided by:
Novo Nordisk
Danish Data Science Academy (NNF21SA0069429)
Aalborg Universitet
Danish Diabetes and Endocrine Academy (NNF22SA0079901)
Aalborg University
Article History
Received: 5 March 2025
Accepted: 3 June 2025
First Online: 4 August 2025
Acknowledgements
: The authors wish to acknowledge the Danish Diabetes Association who participated in and supported this project. Additionally, we would like to thank the people with prediabetes and people with type 2 diabetes, their relatives and healthcare professionals who took part in the online survey questionnaires and in the final workshop. Part of this work was presented as a poster presentation at the 32nd European Congress of Obesity in Malaga in May 2025.
: Individual participant data have been provided to this study on the understanding that it would be confidential and used only for the purpose of analysing research uncertainties and describing participant demographics for the specific study. Thus, data collected for the study will not be released to any third party.
: Open access funding provided by Aalborg University. This work was supported by Aalborg University, Novo Nordisk A/S, and a research grant from the Danish Diabetes and Endocrine Academy (DDEA), funded by the Novo Nordisk Foundation grant number NNF22SA0079901; and the Danish Data Science Academy, funded by the Novo Nordisk Foundation grant number NNF21SA0069429. Aalborg University hosted the project and provided IT support for handling and analysing data. Novo Nordisk A/S, DDEA and Danish Data Science Academy had no role in the study design.
: AKA is a Novo Nordisk employee and has received a PhD grant from the DDEA (grant number NNF22SA0079901) and the Danish Data Science Academy (grant number NNF21SA0069429), funded by the Novo Nordisk Foundation. KF is a Novo Nordisk employee and holds Novo Nordisk shares. Additionally, KF is a member of the DDEA Advisory Board and Board Committee on Strategic Partnerships. DV is a Novo Nordisk employee and holds Novo Nordisk shares. BJS is a Novo Nordisk employee and holds Novo Nordisk shares. MHJ is a Novo Nordisk employee and holds Novo Nordisk shares. The remaining authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.
: AKA, MHJ, KF, DV, BJS, KDL and MSR conceptualised the study. All authors were responsible for protocol writing and investigation. AKA and MHJ collected the data, had full access to all the data in the study and were responsible for data curation and data analysis. AKA and KDL were facilitators in the workshop. AKA and MHJ were project administrators and were responsible for data visualisation. AKA drafted the original manuscript and is the guarantor of this work. All authors reviewed, edited and approved the final manuscript.